Therapeutics Acquisition Corp. Uncategorized Contracts & Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
Therapeutics Acquisition Corp.
Biotechnology
2022
Revised Form of
Therapeutics Acquisition Corp.
Biotechnology
2021
Revised Form of Non
Therapeutics Acquisition Corp.
Biotechnology
2021
Third Amendment to Exclusive Sublicense Agreement, dated September 24, 2021, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Second Amendment to Exclusive Sublicense Agreement, dated January 5, 2021 to be effective as of December 31, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
First Amendment to Exclusive Sublicense Agreement, dated April 14, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Exclusive Sublicense Agreement, dated April 2, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021